Company Long-Term Indebtedness: Sotera Health Corp (SHC)

Public company logo of Sterigenics (SHC)

Sotera Health Company growth is driven by biotech sector demand for sterilization and the opening of new centers. In-house laboratories minimize operational outsourcing, ensuring internal certification. Logistics are delegated to vendors without the risk of strategic dependency. The trajectory of the business's long-term debt visualizes the dynamics of the credit load, where 2.33 shows the current volume of the metric.

SHC soterahealth.com: Company Long-Term Debt in the range 07/04/2022 - 10/31/2026

Summary analytical data breakdowns for Sterigenics (SHC)

- market price and analyst price targets:
Stock Price soterahealth.com|SHC - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Sotera Health|SHC - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Sotera Health|SHC - Company Book Value|Market Value to Book Value Ratio soterahealth.com|SHC - Cumulative Company Assets
- business debt structure and liquidity details:
Debt to Capital Sotera Health Company|SHC - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Nordion|SHC - Company Aggregate Debts|Debts to Net Assets Sotera Health|SHC - Company Long-Term Debt|Short-Term Debt Volume Sotera Health|Interim Coverage Ratio soterahealth.com
- business earnings and investment ratios data:
SHC - Company Net Income
Summary company analytics:SHC soterahealth.com
Manufactured product of Sotera Health Company

Investors are verifying the issuer's stability through debt load analysis, comparing liabilities to equity to assess solvency. The trend in the company's long-term debt reflects the total of loans with maturities exceeding one year, which is critical for Sotera Health Company (SHC) when financing R&D in radiological safety and laboratory automation, confirming the business's ability to scale innovations without the risk of default.

Competitors of Sotera Health Company (SHC)

Company Long-Term Debts agilent.com A|DGX - Company Long-Term Debt|ILMN (Illumina Inc) - Company Long-Term Indebtedness|EXAS: Company Long-Term Debts|Revvity Corp (RVTY) - Company Long-Term Debts|Company Long-Term Debt Bio-Rad Laboratories|Company Long-Term Debt NNNN|Company Long-Term Liabilities QDEL (QuidelOrtho Corporation)|OPK - Long-Term Debt|Company Long-Term Debt caredx.com CDNA|Long-Term Debt Volume Maravai (MRVI)|Fulgent Genetics, Inc. - Company Long-Term Debts|Long-Term Debt Volume fluidigm.com LAB|Cytek Biosciences (CTKB) - Company Long-Term Debt|OSUR - Long-Term Debt Volume|Company Long-Term Debt Exagen Inc|MDxHealth, Inc. (MDXH) - Long-Term Debt Volume|Company Long-Term Debt Lucid Diagnostics Inc. (LUCD)|PRE - Long-Term Debt|Insight Molecular Diagnostics Inc - Company Long-Term Liabilities|Amount of Long-Term Liabilities TRIB (Trinity Biotech PLC)|ProPhase - Company Long-Term Debts|Long-Term Debt Ainos Corporation|Co-Diagnostics, Inc. (CODX) - Company Long-Term Debt|heartsciences.com - Company Long-Term Loans and Borrowings|BMRA (Biomerica) - Company Long-Term Debts|Company Long-Term Debts Cardio Diagnostics Holdings, Inc.|Company Long-Term Liabilities VRAX (Virax Biolabs Group Ltd)|BJDX (Bluejay Diagnostics Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debts AWH (Aspira Women's Health)|Company Long-Term Loans and Borrowings AXDX|CENTOGENE - Company Long-Term Debts|Long-Term Debt Enzo Biochem, Inc.|FRES: Company Long-Term Debts|Genetic Technologies Limited (GENE) - Company Long-Term Debts|Company Long-Term Debt 23andMe Holding Co.|Company Long-Term Debt PMD